Vericel posts record Q3 profit, lifts 2026 revenue and EBITDA margin guidance

Vericel Corp. reported third‑quarter 2026 revenue of $85.4 million, up 26% year‑over‑year, and net income of $14.2 million, a 179% increase, delivering earnings of $0.27 per diluted share. Adjusted EBITDA rose to $25.2 million, representing 30% of revenue, and the company raised its full‑year 2026 revenue outlook to $344 million‑$346 million and its adjusted EBITDA margin target to 28%. It also repurchased 220,744 shares for $8.8 million, leaving $191.2 million of share‑repurchase authorization remaining.

The company says the higher guidance reflects strong MAC I and Burn Care demand, which should support continued earnings growth. Truist Securities raised its price target to $65, citing the results and the raised outlook.

  • 1Q3 2026 revenue was $85.4 million, up 26% YoY.
  • 2Net income increased 179% to $14.2 million, or $0.27 per diluted share.
  • 3Adjusted EBITDA was $25.2 million, equal to 30% of revenue.
  • 4Full‑year 2026 revenue guidance was raised to $344 million‑$346 million.
  • 5Adjusted EBITDA margin guidance was raised to 28%.
  • 6The company repurchased 220,744 shares for $8.8 million, with $191.2 million of authorization remaining.

Sources